BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2024 9:49:53 AM | Browse: 160 | Download: 534
 |
Received |
|
2023-11-02 00:52 |
|
Peer-Review Started |
|
2023-11-02 00:52 |
|
First Decision by Editorial Office Director |
|
2023-11-21 08:18 |
|
Return for Revision |
|
2023-11-21 08:18 |
|
Revised |
|
2023-12-05 04:27 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-01-11 01:08 |
|
Second Decision by Editor-in-Chief |
|
2024-01-15 15:05 |
|
Final Decision by Editorial Office Director |
|
2024-01-18 05:53 |
|
Articles in Press |
|
2024-01-18 05:53 |
|
Edit the Manuscript by Language Editor |
|
2024-01-10 02:17 |
|
Typeset the Manuscript |
|
2024-03-07 03:22 |
|
Publish the Manuscript Online |
|
2024-03-15 09:49 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Basic Study |
| Article Title |
Potential application of Nardostachyos Radix et Rhizoma-Rhubarb for the treatment of diabetic kidney disease based on network pharmacology and cell culture experimental verification
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Meng-Ying Che, Ling Yuan, Jiao Min, Duo-Jie Xu, Dou-Dou Lu, Wen-Jing Liu, Kai-Li Wang, Yan-Yan Wang and Yi Nan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81573695 |
| National Natural Science Foundation of China |
81860894 |
| National Natural Science Foundation of China |
81674096 |
| Ningxia Key Research and Development Plan Project |
2021BEG03106 |
|
| Corresponding Author |
Yi Nan, MD, Professor, Key Laboratory of Ningxia Minority Medicine Modernization Ministry of Education, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, Ningxia Hui Autonomous Region, China. 20080011@nxmu.edu.cn |
| Key Words |
Nardostachyos Radix et Rhizoma-rhubarb; Diabetic kidney disease; Molecular docking; Network pharmacology; Experimental validation |
| Core Tip |
The Nardostachyos Radix et Rhizoma-rhubarb drug pair may upregulate BCL-2 and STAT3 protein expression, and downregulate BAX, Caspase3, and Caspase9 protein expression, thus activating the advanced glycation end products (AGEs)-receptor for AGEs signaling pathway, inhibiting the vitality of TCMK-1 cells, reducing their apoptosis, and arresting them in the G0/G1 phase to protect them from damage by high glucose. |
| Publish Date |
2024-03-15 09:49 |
| Citation |
Che MY, Yuan L, Min J, Xu DJ, Lu DD, Liu WJ, Wang KL, Wang YY, Nan Y. Potential application of Nardostachyos Radix et Rhizoma-Rhubarb for the treatment of diabetic kidney disease based on network pharmacology and cell culture experimental verification. World J Diabetes 2024; 15(3): 530-551 |
| URL |
https://www.wjgnet.com/1948-9358/full/v15/i3/530.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v15.i3.530 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
